Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Offers affordable, high-quality solutions for diabetes care
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
He has over 23 years of experience across sectors
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Subscribe To Our Newsletter & Stay Updated
